ALTEPLASE

ALTEPLASE was reported 15038 times

ALTEPLASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REPERFUSION ARRHYTHMIA 29 0.4754
1 REOCCLUSION 26 0.3333
2 NIH STROKE SCALE SCORE INCREASED 27 0.3253
3 NIH STROKE SCALE ABNORMAL 10 0.3226
4 HAEMORRHAGIC TRANSFORMATION STROKE 441 0.2926
5 CEREBRAL REPERFUSION INJURY 7 0.2917
6 POSTINFARCTION ANGINA 12 0.2222
7 CEREBRAL HYPERPERFUSION SYNDROME 17 0.1868
8 FIBRINOLYSIS INCREASED 7 0.1750
9 STROKE IN EVOLUTION 37 0.1667
10 HAEMORRHAGIC INFARCTION 76 0.1384
11 REPERFUSION INJURY 16 0.1159
12 PRODUCT CLOSURE ISSUE 63 0.1131
13 THROMBOLYSIS 25 0.1126
14 NEUROLOGICAL DECOMPENSATION 197 0.0851
15 HAEMORRHAGIC CEREBRAL INFARCTION 57 0.0812
16 GINGIVAL BLEEDING 1031 0.0754
17 TONGUE HAEMORRHAGE 88 0.0750
18 INTERCEPTED PRODUCT STORAGE ERROR 264 0.0739
19 FIBRINOLYSIS 5 0.0735
20 BLOOD FIBRINOGEN DECREASED 80 0.0701
21 CNS VENTRICULITIS 21 0.0644
22 HERPES SIMPLEX VIRAEMIA 7 0.0560
23 BRAIN MIDLINE SHIFT 28 0.0527
24 INTERCEPTED MEDICATION ERROR 244 0.0526
25 BRAIN STEM HAEMORRHAGE 49 0.0518
26 HAEMORRHAGE INTRACRANIAL 741 0.0495
27 MYOCARDIAL RUPTURE 15 0.0493
28 BASILAR ARTERY OCCLUSION 8 0.0482
29 CEREBRAL MASS EFFECT 17 0.0468
30 EXTRAVASATION BLOOD 11 0.0462
31 PROSTHETIC CARDIAC VALVE THROMBOSIS 5 0.0459
32 RHEGMATOGENOUS RETINAL DETACHMENT 9 0.0431
33 VESSEL PUNCTURE SITE HAEMATOMA 8 0.0406
34 RHYTHM IDIOVENTRICULAR 13 0.0400
35 CEREBRAL HAEMATOMA 125 0.0372
36 PUNCTURE SITE HAEMORRHAGE 26 0.0367
37 BRAIN HERNIATION 105 0.0351
38 PARENTERAL NUTRITION 8 0.0346
39 VERTEBRAL ARTERY DISSECTION 7 0.0343
40 ACCELERATED IDIOVENTRICULAR RHYTHM 5 0.0338
41 BULLOUS HAEMORRHAGIC DERMATOSIS 7 0.0333
42 BASAL GANGLIA HAEMORRHAGE 27 0.0332
43 BLOOD BRAIN BARRIER DEFECT 5 0.0329
44 CORONARY REVASCULARISATION 5 0.0316
45 TONGUE HAEMATOMA 6 0.0303
46 LIVIDITY 11 0.0300
47 RESTRICTIVE CARDIOMYOPATHY 9 0.0297
48 APLASTIC ANAEMIA 150 0.0287
49 CEREBELLAR HAEMATOMA 8 0.0285
50 INTRAVENTRICULAR HAEMORRHAGE 70 0.0281
51 CATHETER SITE HAEMATOMA 8 0.0270
52 CEREBRAL ARTERY OCCLUSION 28 0.0261
53 ARTERY DISSECTION 10 0.0242
54 CHEST WALL HAEMATOMA 6 0.0233
55 CEREBRAL HAEMORRHAGE 827 0.0231
56 THROMBECTOMY 7 0.0217
57 RETINAL PIGMENT EPITHELIAL TEAR 15 0.0216
58 SUBCUTANEOUS HAEMATOMA 26 0.0204
59 BASAL GANGLIA INFARCTION 7 0.0203
60 HYPOFIBRINOGENAEMIA 20 0.0202
61 TONGUE OEDEMA 75 0.0196
62 CEREBRAL ARTERY THROMBOSIS 10 0.0195
63 HYPHAEMA 10 0.0192
64 UROGENITAL HAEMORRHAGE 7 0.0188
65 MOUTH HAEMORRHAGE 124 0.0169
66 COAGULATION TEST ABNORMAL 13 0.0169
67 HAEMOTHORAX 48 0.0165
68 CAROTID ARTERY DISSECTION 7 0.0164
69 MACULAR HOLE 22 0.0164
70 INTRACRANIAL HAEMATOMA 9 0.0160
71 CARDIAC VENTRICULAR THROMBOSIS 20 0.0155
72 CEREBRAL AMYLOID ANGIOPATHY 5 0.0152
73 BRAIN COMPRESSION 6 0.0150
74 COMPARTMENT SYNDROME 39 0.0149
75 PERIPHERAL EMBOLISM 17 0.0147
76 VITREOUS HAEMORRHAGE 40 0.0145
77 TREATMENT DELAYED 25 0.0144
78 CIRCUMORAL OEDEMA 5 0.0143
79 ANGIOEDEMA 631 0.0142
80 NO ADVERSE EVENT 2541 0.0140
81 CATHETER SITE HAEMORRHAGE 35 0.0140
82 SUBARACHNOID HAEMORRHAGE 134 0.0131
83 HEMIANOPIA 13 0.0131
84 RETROPERITONEAL HAEMORRHAGE 32 0.0130
85 CEREBELLAR HAEMORRHAGE 18 0.0126
86 VASOGENIC CEREBRAL OEDEMA 9 0.0125
87 PERICARDIAL HAEMORRHAGE 27 0.0123
88 CEREBRAL ARTERY EMBOLISM 15 0.0123
89 VASCULAR PSEUDOANEURYSM 21 0.0120
90 HAEMORRHAGIC STROKE 94 0.0120
91 VENTRICULAR EXTRASYSTOLES 123 0.0118
92 LIP HAEMORRHAGE 15 0.0118
93 INTRACRANIAL MASS 11 0.0116
94 CARDIAC DEATH 14 0.0116
95 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 38 0.0115
96 POST THROMBOTIC SYNDROME 5 0.0111
97 BRAIN OEDEMA 136 0.0108
98 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 5 0.0107
99 ANAPHYLACTOID SHOCK 5 0.0106
100 THALAMUS HAEMORRHAGE 9 0.0103
101 EMBOLIC STROKE 36 0.0102
102 EXTRAVASATION 42 0.0102
103 PLATELET TRANSFUSION 13 0.0101
104 ISCHAEMIC STROKE 180 0.0101
105 INCISION SITE HAEMORRHAGE 8 0.0099
106 BRAIN STEM INFARCTION 10 0.0098
107 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 9 0.0097
108 MUCOSAL HAEMORRHAGE 11 0.0095
109 PRODUCT TEMPERATURE EXCURSION ISSUE 48 0.0093
110 CEREBRAL ISCHAEMIA 48 0.0093
111 HAEMORRHAGE SUBCUTANEOUS 33 0.0093
112 ABDOMINAL WALL HAEMATOMA 18 0.0092
113 STREPTOCOCCAL BACTERAEMIA 10 0.0092
114 INTERLEUKIN LEVEL INCREASED 5 0.0091
115 CEREBRAL INFARCTION 218 0.0089
116 RENAL VEIN THROMBOSIS 6 0.0089
117 HEART TRANSPLANT 8 0.0088
118 ANEURYSM RUPTURED 8 0.0087
119 ECCHYMOSIS 59 0.0086
120 RETROPERITONEAL HAEMATOMA 19 0.0086
121 ENDOTRACHEAL INTUBATION COMPLICATION 5 0.0085
122 VENA CAVA THROMBOSIS 14 0.0084
123 JOINT CONTRACTURE 9 0.0084
124 EXTRADURAL HAEMATOMA 11 0.0083
125 DEVICE RELATED THROMBOSIS 8 0.0081
126 HYDROCEPHALUS 44 0.0081
127 AMPUTATION 10 0.0080
128 PERITONEAL HAEMORRHAGE 11 0.0079
129 VENTRICULAR TACHYCARDIA 130 0.0079
130 PERIPHERAL ARTERY OCCLUSION 11 0.0078
131 HYPERCHLORAEMIA 5 0.0078
132 STRIDOR 23 0.0078
133 VASOSPASM 7 0.0076
134 BLOOD FIBRINOGEN INCREASED 6 0.0076
135 ELECTROMECHANICAL DISSOCIATION 6 0.0075
136 HAEMOPERITONEUM 6 0.0075
137 EMBOLISM ARTERIAL 9 0.0075
138 CRANIAL NERVE DISORDER 5 0.0072
139 INTRA-ABDOMINAL HAEMORRHAGE 17 0.0071
140 BRAIN DEATH 22 0.0071
141 EMBOLISM 59 0.0071
142 CAROTID ARTERY THROMBOSIS 6 0.0071
143 CEREBRAL VENTRICLE DILATATION 8 0.0069
144 CARDIAC TAMPONADE 33 0.0069
145 VENTRICULAR FIBRILLATION 77 0.0069
146 HEPARIN-INDUCED THROMBOCYTOPENIA 34 0.0069
147 APALLIC SYNDROME 5 0.0069
148 ISCHAEMIC CEREBRAL INFARCTION 8 0.0069
149 NODAL RHYTHM 10 0.0068
150 HEMIANOPIA HOMONYMOUS 5 0.0068
151 DYSPHORIA 34 0.0067
152 PRODUCT RECONSTITUTION QUALITY ISSUE 6 0.0067
153 BRAIN STEM SYNDROME 5 0.0067
154 PULMONARY ARTERY THROMBOSIS 5 0.0065
155 ENDOTRACHEAL INTUBATION 18 0.0064
156 HEMIPLEGIA 53 0.0064
157 PERIPHERAL ISCHAEMIA 26 0.0064
158 HAEMATOMA 164 0.0063
159 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 8 0.0063
160 RENAL INFARCT 9 0.0062
161 SUBDURAL HAEMORRHAGE 17 0.0062
162 PERFORATION 5 0.0062
163 INTRACARDIAC THROMBUS 19 0.0062
164 HYPERPHOSPHATAEMIA 13 0.0060
165 ADMINISTRATION SITE EXTRAVASATION 6 0.0060
166 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
167 CEREBELLAR INFARCTION 10 0.0059
168 CARDIOGENIC SHOCK 84 0.0058
169 ATRIAL THROMBOSIS 12 0.0058
170 SPLENIC INFARCTION 10 0.0057
171 ARTERIAL THROMBOSIS 11 0.0057
172 PHARYNGEAL HAEMORRHAGE 7 0.0057
173 ISCHAEMIA 26 0.0057
174 FIBRIN D DIMER INCREASED 20 0.0056
175 INTRACRANIAL PRESSURE INCREASED 31 0.0056
176 EMPYEMA 11 0.0055
177 PRIMARY SEQUESTRUM 5 0.0055
178 HAEMORRHAGE 577 0.0055
179 INTESTINAL INFARCTION 5 0.0055
180 SPLENIC RUPTURE 9 0.0055
181 HAEMOGLOBINURIA 6 0.0054
182 CATHETER SITE SWELLING 5 0.0053
183 GAZE PALSY 9 0.0053
184 INFECTIOUS PLEURAL EFFUSION 8 0.0053
185 HEMIPARESIS 89 0.0052
186 AMYLOIDOSIS 9 0.0052
187 CARBON DIOXIDE DECREASED 6 0.0052
188 CAROTID ARTERY OCCLUSION 19 0.0052
189 VENTRICULAR ARRHYTHMIA 19 0.0052
190 AORTIC DISSECTION 21 0.0051
191 LARYNGEAL OEDEMA 31 0.0050
192 VOCAL CORD PARALYSIS 9 0.0050
193 EXTRASYSTOLES 35 0.0050
194 LIP OEDEMA 21 0.0050
195 HYPOGONADISM 5 0.0049
196 AREFLEXIA 13 0.0049
197 BLOOD LOSS ANAEMIA 11 0.0049
198 CONSCIOUSNESS FLUCTUATING 5 0.0048
199 SWOLLEN TONGUE 149 0.0048
200 ENTEROCOCCAL BACTERAEMIA 5 0.0047
201 INTRACRANIAL VENOUS SINUS THROMBOSIS 5 0.0047
202 PRODUCT CONTAINER ISSUE 40 0.0047
203 PROCEDURAL HAEMORRHAGE 18 0.0046
204 PRODUCT NAME CONFUSION 5 0.0046
205 EXTREMITY NECROSIS 8 0.0046
206 THROMBOSIS IN DEVICE 15 0.0046
207 PRODUCT STORAGE ERROR 391 0.0045
208 KLEBSIELLA SEPSIS 5 0.0044
209 MONOPARESIS 8 0.0044
210 VENOOCCLUSIVE DISEASE 11 0.0044
211 INFARCTION 30 0.0044
212 VENTRICULAR HYPOKINESIA 14 0.0044
213 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
214 AORTIC THROMBOSIS 5 0.0043
215 PUPILLARY REFLEX IMPAIRED 8 0.0043
216 PERIPHERAL ARTERY THROMBOSIS 6 0.0043
217 VASCULAR OCCLUSION 9 0.0043
218 BRADYARRHYTHMIA 7 0.0043
219 PELVIC VENOUS THROMBOSIS 6 0.0042
220 HAEMATOMA MUSCLE 5 0.0042
221 BLEEDING TIME PROLONGED 5 0.0041
222 PULMONARY HAEMORRHAGE 32 0.0041
223 APLASIA 8 0.0041
224 PUPIL FIXED 7 0.0040
225 BLOOD UREA DECREASED 5 0.0040
226 PLEURITIC PAIN 11 0.0040
227 CEREBROVASCULAR DISORDER 12 0.0040
228 OEDEMA MOUTH 13 0.0040
229 HAEMORRHAGE URINARY TRACT 10 0.0039
230 BLOOD PRESSURE IMMEASURABLE 6 0.0039
231 RETINAL DETACHMENT 36 0.0039
232 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6 0.0039
233 QUADRIPLEGIA 8 0.0039
234 COAGULATION TIME PROLONGED 6 0.0039
235 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 10 0.0039
236 COAGULOPATHY 64 0.0038
237 LIVEDO RETICULARIS 8 0.0038
238 HAEMODYNAMIC INSTABILITY 29 0.0038
239 INCORRECT PRODUCT STORAGE 50 0.0038
240 ADENOVIRUS INFECTION 11 0.0038
241 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
242 HYPERCOAGULATION 7 0.0037
243 ISCHAEMIC HEPATITIS 5 0.0036
244 RETINAL HAEMORRHAGE 26 0.0036
245 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
246 LEG AMPUTATION 15 0.0036
247 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
248 QUADRIPARESIS 6 0.0036
249 PARESIS 8 0.0036
250 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
251 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
252 INJECTION SITE OEDEMA 6 0.0035
253 METHAEMOGLOBINAEMIA 8 0.0035
254 NEUTROPENIC COLITIS 7 0.0034
255 INFUSION SITE EXTRAVASATION 21 0.0034
256 JUGULAR VEIN THROMBOSIS 6 0.0034
257 SPINAL CORD COMPRESSION 13 0.0033
258 VENOUS OCCLUSION 6 0.0033
259 INCORRECT DRUG ADMINISTRATION RATE 14 0.0033
260 CONTRAINDICATION TO MEDICAL TREATMENT 5 0.0033
261 PRODUCT PREPARATION ERROR 67 0.0033
262 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
263 ANAPHYLACTOID REACTION 13 0.0032
264 UPPER GASTROINTESTINAL HAEMORRHAGE 53 0.0031
265 TRANSFUSION 33 0.0031
266 CYTOKINE RELEASE SYNDROME 63 0.0031
267 ATRIOVENTRICULAR BLOCK COMPLETE 21 0.0031
268 ATELECTASIS 30 0.0031
269 OCCULT BLOOD POSITIVE 6 0.0031
270 FACIAL PARALYSIS 26 0.0030
271 ACUTE RESPIRATORY FAILURE 58 0.0030
272 HYPERNATRAEMIA 15 0.0030
273 MUSCLE HAEMORRHAGE 12 0.0030
274 HYPERCAPNIA 9 0.0030
275 CORONARY ARTERY THROMBOSIS 6 0.0030
276 EMBOLISM VENOUS 9 0.0030
277 SHOCK 68 0.0030
278 HAEMATURIA 101 0.0029
279 TACHYPNOEA 40 0.0029
280 INJECTION SITE EXTRAVASATION 36 0.0029
281 DEVICE OCCLUSION 41 0.0029
282 SINUS BRADYCARDIA 28 0.0029
283 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 17 0.0029
284 SHOCK HAEMORRHAGIC 23 0.0028
285 PRODUCT CONTAMINATION 10 0.0028
286 NEUROLOGICAL SYMPTOM 16 0.0028
287 MUCOSAL INFLAMMATION 73 0.0028
288 BRADYCARDIA 147 0.0028
289 PRODUCT PREPARATION ISSUE 18 0.0027
290 PULSE ABSENT 13 0.0027
291 RIGHT VENTRICULAR FAILURE 19 0.0027
292 BACTERAEMIA 32 0.0027
293 APHASIA 81 0.0027
294 ANGIOPATHY 15 0.0027
295 SINUS TACHYCARDIA 38 0.0027
296 RESPIRATORY FAILURE 195 0.0027
297 MULTI-ORGAN FAILURE 46 0.0027
298 CENTRAL VENOUS CATHETERISATION 8 0.0026
299 LIP SWELLING 88 0.0026
300 PNEUMONIA ASPIRATION 66 0.0026
301 ACUTE MYOCARDIAL INFARCTION 77 0.0026
302 VIITH NERVE PARALYSIS 9 0.0026
303 HAEMATEMESIS 66 0.0026
304 ESCHERICHIA BACTERAEMIA 6 0.0025
305 COMA 121 0.0025
306 HYPERAEMIA 5 0.0025
307 STAPHYLOCOCCAL BACTERAEMIA 11 0.0025
308 CONJUNCTIVAL HYPERAEMIA 9 0.0025
309 HAEMOPTYSIS 70 0.0025
310 FAILURE TO THRIVE 13 0.0025
311 CEREBRAL THROMBOSIS 7 0.0025
312 VASCULAR GRAFT 7 0.0024
313 SKIN INDURATION 5 0.0024
314 PROTEIN TOTAL DECREASED 9 0.0024
315 ATRIAL FLUTTER 19 0.0024
316 DILATATION VENTRICULAR 5 0.0024
317 SUBDURAL HAEMATOMA 34 0.0024
318 PROTHROMBIN TIME PROLONGED 14 0.0023
319 ARTERIOSCLEROSIS 22 0.0023
320 AORTIC ARTERIOSCLEROSIS 6 0.0023
321 RESPIRATORY DISTRESS 64 0.0023
322 SPUTUM INCREASED 5 0.0023
323 HYPOVOLAEMIC SHOCK 11 0.0023
324 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
325 CEREBRAL ATROPHY 9 0.0023
326 HYPOXIA 78 0.0022
327 CLONUS 6 0.0022
328 HYPOPHOSPHATAEMIA 16 0.0022
329 OBSTRUCTIVE AIRWAYS DISORDER 24 0.0022
330 OFF LABEL USE 1883 0.0021
331 CARDIAC ARREST 175 0.0021
332 OXYGEN SATURATION ABNORMAL 6 0.0021
333 TUMOUR HAEMORRHAGE 6 0.0021
334 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
335 ACIDOSIS 16 0.0021
336 METASTATIC NEOPLASM 9 0.0021
337 PARAPLEGIA 6 0.0021
338 RALES 12 0.0021
339 APNOEA 16 0.0021
340 PULMONARY EMBOLISM 195 0.0020
341 HYPOVOLAEMIA 12 0.0020
342 PETECHIAE 21 0.0020
343 HYPERPARATHYROIDISM SECONDARY 5 0.0020
344 DISSEMINATED INTRAVASCULAR COAGULATION 28 0.0020
345 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
346 HAEMORRHAGIC DIATHESIS 7 0.0020
347 INTENTIONAL PRODUCT USE ISSUE 172 0.0020
348 INTRAOCULAR PRESSURE INCREASED 25 0.0020
349 FIBROSIS 6 0.0019
350 BONE LESION 7 0.0019
351 BLOOD PHOSPHORUS DECREASED 7 0.0019
352 CYANOSIS 30 0.0019
353 EYE MOVEMENT DISORDER 13 0.0019
354 RADICULOPATHY 5 0.0019
355 SERUM FERRITIN INCREASED 10 0.0019
356 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 64 0.0019
357 DYSARTHRIA 71 0.0019
358 BLOOD CREATINE PHOSPHOKINASE INCREASED 54 0.0019
359 ENCEPHALOPATHY 46 0.0019
360 LOOSE TOOTH 6 0.0019
361 FEBRILE NEUTROPENIA 122 0.0018
362 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10 0.0018
363 MENTAL STATUS CHANGES 51 0.0018
364 MEDICATION ERROR 102 0.0018
365 GASTROINTESTINAL HAEMORRHAGE 153 0.0018
366 DEPRESSED LEVEL OF CONSCIOUSNESS 72 0.0018
367 DEVICE RELATED INFECTION 28 0.0018
368 ANAPHYLACTIC REACTION 100 0.0018
369 ANEURYSM 9 0.0018
370 NO THERAPEUTIC RESPONSE 22 0.0018
371 CARDIOPULMONARY FAILURE 7 0.0018
372 LUNG CONSOLIDATION 5 0.0018
373 VENOUS THROMBOSIS 7 0.0018
374 PNEUMONIA FUNGAL 7 0.0018
375 HAEMATOCRIT DECREASED 35 0.0018
376 PHLEBITIS 9 0.0018
377 MYOCARDIAL ISCHAEMIA 20 0.0018
378 CEREBRAL DISORDER 13 0.0018
379 LEFT VENTRICULAR FAILURE 6 0.0017
380 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
381 HYPOTENSION 347 0.0017
382 LOCALISED OEDEMA 8 0.0017
383 NEPHROGENIC ANAEMIA 8 0.0017
384 EPISTAXIS 129 0.0017
385 SEPTIC SHOCK 75 0.0017
386 DEEP VEIN THROMBOSIS 112 0.0017
387 CAROTID ARTERY STENOSIS 6 0.0017
388 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7 0.0017
389 ABORTION 5 0.0017
390 LUMBAR SPINAL STENOSIS 5 0.0017
391 TUMOUR LYSIS SYNDROME 15 0.0017
392 SKIN TIGHTNESS 8 0.0017
393 SKIN ABRASION 8 0.0017
394 ANGINA UNSTABLE 11 0.0017
395 PERICARDIAL EFFUSION 39 0.0017
396 CONGESTIVE CARDIOMYOPATHY 7 0.0017
397 GANGRENE 10 0.0017
398 LEUKOCYTOSIS 30 0.0017
399 CARDIAC FAILURE ACUTE 11 0.0016
400 PURULENT DISCHARGE 7 0.0016
401 INTESTINAL ISCHAEMIA 9 0.0016
402 POST PROCEDURAL HAEMORRHAGE 19 0.0016
403 ANAPHYLACTIC SHOCK 42 0.0016
404 UNRESPONSIVE TO STIMULI 42 0.0016
405 PHARYNGEAL OEDEMA 25 0.0016
406 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
407 PORTAL HYPERTENSION 5 0.0016
408 ACUTE PULMONARY OEDEMA 9 0.0016
409 URINE OUTPUT DECREASED 14 0.0016
410 NEUROTOXICITY 28 0.0016
411 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
412 INTERNATIONAL NORMALISED RATIO INCREASED 45 0.0016
413 PATHOLOGICAL FRACTURE 8 0.0016
414 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
415 ENDOCARDITIS 8 0.0016
416 ASPIRATION 17 0.0016
417 PULMONARY HYPERTENSION 32 0.0015
418 INJECTION SITE INFECTION 5 0.0015
419 INFUSION SITE HAEMORRHAGE 5 0.0015
420 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
421 PULMONARY OEDEMA 67 0.0015
422 POTENTIATING DRUG INTERACTION 5 0.0015
423 METASTASES TO SPINE 5 0.0015
424 GINGIVITIS 8 0.0015
425 COLITIS ISCHAEMIC 10 0.0015
426 ARRHYTHMIA 70 0.0015
427 DECUBITUS ULCER 12 0.0015
428 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
429 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
430 CEREBROVASCULAR ACCIDENT 248 0.0015
431 CHEST PAIN 270 0.0015
432 INTERNATIONAL NORMALISED RATIO ABNORMAL 5 0.0015
433 OLIGURIA 9 0.0014
434 ENCEPHALITIS 10 0.0014
435 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
436 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
437 COVID-19 PNEUMONIA 17 0.0014
438 PROCEDURAL COMPLICATION 11 0.0014
439 PRODUCT LEAKAGE 8 0.0014
440 CLOSTRIDIUM DIFFICILE COLITIS 15 0.0014
441 MITRAL VALVE INCOMPETENCE 16 0.0014
442 BRONCHOSPASM 20 0.0014
443 HIATUS HERNIA 18 0.0014
444 PNEUMOTHORAX 22 0.0014
445 CARDIO-RESPIRATORY ARREST 58 0.0014
446 DEATH 1194 0.0014
447 TRICUSPID VALVE INCOMPETENCE 11 0.0014
448 PULMONARY FUNCTION TEST DECREASED 6 0.0014
449 BLOOD PRESSURE DECREASED 91 0.0014
450 OXYGEN SATURATION DECREASED 76 0.0014
451 MENINGITIS 9 0.0013
452 PRODUCT COMPLAINT 34 0.0013
453 BLOOD CALCIUM DECREASED 15 0.0013
454 SKIN LACERATION 14 0.0013
455 ANURIA 11 0.0013
456 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
457 BLOOD ALBUMIN DECREASED 10 0.0013
458 SPINAL OSTEOARTHRITIS 11 0.0013
459 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
460 LUNG INFILTRATION 11 0.0012
461 COMPLICATION ASSOCIATED WITH DEVICE 18 0.0012
462 SEPSIS 138 0.0012
463 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
464 INTERCEPTED PRODUCT PREPARATION ERROR 15 0.0012
465 CORONARY ARTERY BYPASS 7 0.0012
466 PALLOR 33 0.0012
467 ATRIAL FIBRILLATION 118 0.0012
468 STRESS CARDIOMYOPATHY 7 0.0012
469 BRAIN INJURY 12 0.0012
470 PARALYSIS 17 0.0012
471 TROPONIN INCREASED 9 0.0012
472 HYPERPYREXIA 5 0.0012
473 HAEMOGLOBIN DECREASED 120 0.0012
474 ATRIOVENTRICULAR BLOCK 9 0.0012
475 RESPIRATORY ARREST 32 0.0012
476 HYPERBILIRUBINAEMIA 12 0.0012
477 INJECTION SITE VESICLES 7 0.0012
478 STATUS EPILEPTICUS 13 0.0011
479 HYPERTRANSAMINASAEMIA 8 0.0011
480 SUDDEN DEATH 12 0.0011
481 ABDOMINAL ABSCESS 5 0.0011
482 GASTRIC HAEMORRHAGE 13 0.0011
483 COMPRESSION FRACTURE 6 0.0011
484 DRUG ADMINISTRATION ERROR 34 0.0011
485 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
486 ACUTE CORONARY SYNDROME 9 0.0011
487 PLEURAL EFFUSION 66 0.0011
488 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
489 BLOOD UREA INCREASED 18 0.0011
490 MALNUTRITION 12 0.0011
491 PULMONARY CONGESTION 14 0.0011
492 CARDIAC FAILURE 85 0.0011
493 GENERALISED OEDEMA 13 0.0010
494 DRUG INTERACTION 166 0.0010
495 RESPIRATORY DISORDER 31 0.0010
496 WRONG PRODUCT ADMINISTERED 7 0.0010
497 TACHYCARDIA 92 0.0010
498 EYELID OEDEMA 12 0.0010
499 SKIN WARM 6 0.0010
500 HYPOALBUMINAEMIA 8 0.0010
501 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
502 ASCITES 30 0.0010
503 CENTRAL NERVOUS SYSTEM LESION 14 0.0010
504 CHEST DISCOMFORT 104 0.0010
505 BREATH SOUNDS ABNORMAL 5 0.0010
506 STAPHYLOCOCCAL SEPSIS 5 0.0010
507 HYPERVOLAEMIA 5 0.0010
508 ORGANISING PNEUMONIA 5 0.0010
509 ODYNOPHAGIA 6 0.0010
510 PANCYTOPENIA 56 0.0010
511 OEDEMA 54 0.0010
512 HEPATIC FAILURE 30 0.0010
513 CORONARY ARTERY STENOSIS 5 0.0010
514 KLEBSIELLA INFECTION 5 0.0010
515 PNEUMONIA BACTERIAL 9 0.0010
516 NEUTROPENIC SEPSIS 7 0.0010
517 HYPOKALAEMIA 45 0.0010
518 GRAFT VERSUS HOST DISEASE 7 0.0010
519 STAPHYLOCOCCAL INFECTION 32 0.0010
520 NERVOUS SYSTEM DISORDER 30 0.0010
521 FLANK PAIN 9 0.0010
522 PRODUCT QUALITY ISSUE 130 0.0010
523 RESTLESSNESS 35 0.0010
524 PARTIAL SEIZURES 5 0.0010
525 BLOOD LACTIC ACID INCREASED 5 0.0009
526 THROMBOCYTOPENIA 106 0.0009
527 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
528 ELECTROLYTE IMBALANCE 11 0.0009
529 THROMBOSIS 76 0.0009
530 NYSTAGMUS 5 0.0009
531 CIRCULATORY COLLAPSE 16 0.0009
532 VITAMIN D DEFICIENCY 9 0.0009
533 ACUTE KIDNEY INJURY 141 0.0009
534 HYPERTHERMIA 7 0.0009
535 HEPATOMEGALY 9 0.0009
536 CARDIAC FAILURE CONGESTIVE 73 0.0009
537 HAEMOLYSIS 7 0.0009
538 RESPIRATORY RATE INCREASED 8 0.0009
539 ACUTE MYELOID LEUKAEMIA 14 0.0009
540 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
541 PNEUMONIA 290 0.0009
542 SMALL INTESTINAL OBSTRUCTION 11 0.0009
543 MOTOR DYSFUNCTION 9 0.0009
544 SEIZURE 102 0.0009
545 INTERNAL HAEMORRHAGE 10 0.0009
546 ANGINA PECTORIS 25 0.0009
547 RENAL FAILURE ACUTE 37 0.0009
548 SENSORY LOSS 7 0.0009
549 IRON DEFICIENCY ANAEMIA 8 0.0009
550 MOUTH SWELLING 5 0.0009
551 GRAND MAL CONVULSION 8 0.0009
552 TENDERNESS 9 0.0009
553 BLOOD PRESSURE INCREASED 132 0.0009
554 BACTERIAL INFECTION 16 0.0009
555 ASPHYXIA 7 0.0009
556 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
557 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
558 HAIR DISORDER 7 0.0008
559 LYMPHOCYTE COUNT DECREASED 15 0.0008
560 HYPERHIDROSIS 108 0.0008
561 ENDOPHTHALMITIS 5 0.0008
562 OSTEOMYELITIS 15 0.0008
563 SPEECH DISORDER 43 0.0008
564 EPILEPSY 25 0.0008
565 CARDIOMEGALY 10 0.0008
566 PAIN IN JAW 23 0.0008
567 DYSPHAGIA 77 0.0008
568 HYPERGLYCAEMIA 29 0.0008
569 INFUSION SITE SWELLING 5 0.0008
570 RECTAL HAEMORRHAGE 34 0.0008
571 AORTIC ANEURYSM 6 0.0008
572 WRONG DRUG ADMINISTERED 7 0.0008
573 METABOLIC ACIDOSIS 25 0.0008
574 NEUTROPHIL COUNT INCREASED 8 0.0008
575 ANAEMIA 149 0.0008
576 POST PROCEDURAL COMPLICATION 15 0.0008
577 RENAL FAILURE CHRONIC 6 0.0008
578 EJECTION FRACTION DECREASED 12 0.0008
579 BONE DISORDER 14 0.0008
580 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
581 UROSEPSIS 7 0.0008
582 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
583 DEFORMITY 7 0.0007
584 TREATMENT FAILURE 62 0.0007
585 MYASTHENIA GRAVIS 6 0.0007
586 PRODUCT ADMINISTRATION ERROR 15 0.0007
587 PRODUCT PACKAGING ISSUE 7 0.0007
588 VOMITING 345 0.0007
589 HICCUPS 6 0.0007
590 PERIPHERAL COLDNESS 10 0.0007
591 MELAENA 16 0.0007
592 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
593 HYPERCHOLESTEROLAEMIA 7 0.0007
594 MYOCARDIAL INFARCTION 126 0.0007
595 SECOND PRIMARY MALIGNANCY 6 0.0007
596 HYPOMAGNESAEMIA 10 0.0007
597 PYREXIA 247 0.0007
598 RENAL TUBULAR NECROSIS 7 0.0007
599 SENSATION OF FOREIGN BODY 6 0.0007
600 CARDIOVASCULAR DISORDER 18 0.0007
601 LUNG INFECTION 11 0.0007
602 HYPOPHAGIA 18 0.0007
603 DERMATITIS CONTACT 8 0.0007
604 HYPOTONIA 7 0.0007
605 PREGNANCY 14 0.0007
606 BLOOD POTASSIUM DECREASED 21 0.0007
607 SKIN HYPERPIGMENTATION 6 0.0007
608 LETHARGY 40 0.0007
609 PSYCHOLOGICAL TRAUMA 6 0.0007
610 DERMATITIS BULLOUS 5 0.0007
611 ABSCESS 11 0.0007
612 MADAROSIS 8 0.0007
613 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
614 BONE MARROW FAILURE 14 0.0007
615 FLUID OVERLOAD 10 0.0007
616 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
617 ORAL DISORDER 5 0.0007
618 PURPURA 6 0.0007
619 SKIN HAEMORRHAGE 10 0.0007
620 ORAL PAIN 15 0.0007
621 HAEMOLYTIC ANAEMIA 6 0.0007
622 CYTOPENIA 8 0.0007
623 FACE OEDEMA 11 0.0007
624 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
625 HAIR COLOUR CHANGES 8 0.0006
626 PLATELET COUNT DECREASED 68 0.0006
627 DYSPNOEA EXERTIONAL 24 0.0006
628 COLITIS 24 0.0006
629 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
630 FURUNCLE 5 0.0006
631 LOCAL SWELLING 11 0.0006
632 HYPERTENSIVE CRISIS 7 0.0006
633 HYPERTENSION 133 0.0006
634 COLD SWEAT 11 0.0006
635 NEPHROPATHY TOXIC 7 0.0006
636 MYDRIASIS 8 0.0006
637 VAGINAL HAEMORRHAGE 27 0.0006
638 DYSPNOEA 349 0.0006
639 POLYURIA 5 0.0006
640 PULMONARY MASS 9 0.0006
641 END STAGE RENAL DISEASE 11 0.0006
642 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
643 HAEMODIALYSIS 5 0.0006
644 PERICARDITIS 10 0.0006
645 CONVULSION 34 0.0006
646 DRUG EFFECT DECREASED 32 0.0006
647 STOMATITIS 36 0.0006
648 INFUSION SITE ERYTHEMA 5 0.0006
649 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
650 HYPERSENSITIVITY 110 0.0006
651 BLOOD BILIRUBIN INCREASED 16 0.0006
652 ATAXIA 7 0.0006
653 MUSCULAR WEAKNESS 67 0.0006
654 TOOTH ABSCESS 6 0.0006
655 HYPERLIPIDAEMIA 7 0.0006
656 POLYNEUROPATHY 7 0.0006
657 CORONARY ARTERY OCCLUSION 8 0.0006
658 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 105 0.0006
659 BLOOD CREATININE INCREASED 38 0.0006
660 TEMPERATURE INTOLERANCE 6 0.0006
661 HYPOCALCAEMIA 11 0.0006
662 POOR VENOUS ACCESS 6 0.0006
663 PERITONITIS 12 0.0006
664 CARDIAC MURMUR 5 0.0006
665 ADRENAL INSUFFICIENCY 7 0.0006
666 DELIRIUM 20 0.0006
667 PRESYNCOPE 14 0.0006
668 GLAUCOMA 11 0.0006
669 RESPIRATORY DEPRESSION 7 0.0006
670 HYPERCALCAEMIA 7 0.0006
671 IMMUNOSUPPRESSION 5 0.0006
672 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
673 RENAL FAILURE 75 0.0006
674 HAEMORRHOIDS 11 0.0006
675 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
676 RED BLOOD CELL COUNT DECREASED 16 0.0006
677 NEUROPATHY PERIPHERAL 53 0.0006
678 INJECTION SITE HAEMATOMA 8 0.0006
679 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
680 GASTROENTERITIS 8 0.0005
681 DEVICE ISSUE 49 0.0005
682 OEDEMA PERIPHERAL 66 0.0005
683 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
684 BODY TEMPERATURE INCREASED 11 0.0005
685 CONFUSIONAL STATE 87 0.0005
686 CHILLS 63 0.0005
687 PLATELET COUNT INCREASED 7 0.0005
688 RASH PAPULAR 12 0.0005
689 INFUSION RELATED REACTION 35 0.0005
690 SPUTUM DISCOLOURED 5 0.0005
691 OSTEOPENIA 8 0.0005
692 HAIR TEXTURE ABNORMAL 7 0.0005
693 MUSCLE TWITCHING 12 0.0005
694 NEUTROPHIL COUNT DECREASED 21 0.0005
695 HEART RATE DECREASED 18 0.0005
696 HEPATIC FUNCTION ABNORMAL 19 0.0005
697 MYOCLONUS 6 0.0005
698 BLINDNESS UNILATERAL 7 0.0005
699 LACTIC ACIDOSIS 16 0.0005
700 AGITATION 36 0.0005
701 DRUG INEFFECTIVE 646 0.0005
702 OSTEONECROSIS OF JAW 12 0.0005
703 HYPERKALAEMIA 17 0.0005
704 DEVICE MALFUNCTION 34 0.0005
705 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
706 ILEUS 6 0.0005
707 UPPER RESPIRATORY TRACT INFECTION 22 0.0005
708 MUSCLE ATROPHY 6 0.0005
709 GASTRIC ULCER 9 0.0005
710 URINARY INCONTINENCE 14 0.0005
711 NAUSEA 372 0.0005
712 RETCHING 10 0.0005
713 SCAR 8 0.0005
714 MUSCULOSKELETAL DISCOMFORT 8 0.0005
715 FLUSHING 47 0.0005
716 DYSURIA 17 0.0005
717 RESPIRATORY TRACT INFECTION 12 0.0005
718 URTICARIA 77 0.0005
719 MENTAL DISORDER 20 0.0005
720 PRODUCT DISPENSING ERROR 10 0.0005
721 ANHEDONIA 12 0.0005
722 GASTRITIS 12 0.0005
723 DISABILITY 9 0.0005
724 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
725 NEURALGIA 11 0.0005
726 MUSCULOSKELETAL CHEST PAIN 7 0.0005
727 THERAPY PARTIAL RESPONDER 7 0.0004
728 JOINT RANGE OF MOTION DECREASED 6 0.0004
729 SWELLING FACE 29 0.0004
730 PNEUMONITIS 12 0.0004
731 ULCER 7 0.0004
732 HEART RATE INCREASED 43 0.0004
733 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
734 LOSS OF CONSCIOUSNESS 55 0.0004
735 INFECTION 62 0.0004
736 ABDOMINAL PAIN 99 0.0004
737 HEPATOCELLULAR INJURY 6 0.0004
738 FRACTURE 8 0.0004
739 WHEEZING 25 0.0004
740 MUSCULOSKELETAL DISORDER 8 0.0004
741 LIMB DISCOMFORT 13 0.0004
742 CHOLECYSTITIS 5 0.0004
743 URINARY RETENTION 14 0.0004
744 SLEEP APNOEA SYNDROME 8 0.0004
745 IMPAIRED QUALITY OF LIFE 6 0.0004
746 RENAL IMPAIRMENT 35 0.0004
747 OSTEOPOROSIS 17 0.0004
748 HEADACHE 259 0.0004
749 NEUTROPENIA 56 0.0004
750 CARDIOMYOPATHY 6 0.0004
751 DISEASE PROGRESSION 48 0.0004
752 CONTUSION 39 0.0004
753 SINUS DISORDER 8 0.0004
754 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
755 HYPOAESTHESIA ORAL 6 0.0004
756 PRODUCTIVE COUGH 19 0.0004
757 DERMATITIS ALLERGIC 5 0.0004
758 CORONARY ARTERY DISEASE 12 0.0004
759 DEVICE FAILURE 6 0.0004
760 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
761 INFUSION SITE PAIN 5 0.0004
762 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
763 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
764 RESTLESS LEGS SYNDROME 7 0.0004
765 C-REACTIVE PROTEIN INCREASED 14 0.0004
766 SARS-COV-2 TEST POSITIVE 5 0.0004
767 OSTEOARTHRITIS 16 0.0004
768 CONJUNCTIVITIS 7 0.0004
769 OBESITY 6 0.0004
770 DYSPHONIA 22 0.0004
771 COUGH 104 0.0004
772 MUSCLE TIGHTNESS 6 0.0004
773 THROAT TIGHTNESS 10 0.0004
774 CHRONIC KIDNEY DISEASE 28 0.0004
775 METASTASES TO BONE 6 0.0004
776 PULMONARY FIBROSIS 7 0.0004
777 ASTHENIA 137 0.0004
778 HYPOAESTHESIA 54 0.0004
779 DISCOMFORT 22 0.0004
780 ORAL DISCOMFORT 5 0.0004
781 RASH MACULO-PAPULAR 8 0.0004
782 FEELING COLD 10 0.0004
783 BACK PAIN 83 0.0004
784 THERAPY NON-RESPONDER 16 0.0004
785 CANDIDA INFECTION 6 0.0004
786 HYPONATRAEMIA 20 0.0004
787 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
788 PAIN 214 0.0003
789 NEOPLASM MALIGNANT 23 0.0003
790 LIVER FUNCTION TEST ABNORMAL 10 0.0003
791 MOVEMENT DISORDER 11 0.0003
792 METASTASES TO LIVER 6 0.0003
793 TOOTH LOSS 7 0.0003
794 CELLULITIS 17 0.0003
795 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
796 IMMUNODEFICIENCY 5 0.0003
797 ABDOMINAL DISTENSION 35 0.0003
798 IMPAIRED HEALING 11 0.0003
799 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
800 ECONOMIC PROBLEM 5 0.0003
801 ILL-DEFINED DISORDER 20 0.0003
802 INJURY 23 0.0003
803 SKIN DISCOLOURATION 15 0.0003
804 MUSCULOSKELETAL PAIN 17 0.0003
805 DEHYDRATION 43 0.0003
806 DEVICE DISLOCATION 14 0.0003
807 CONDITION AGGRAVATED 97 0.0003
808 BLOOD SODIUM DECREASED 6 0.0003
809 URINARY TRACT INFECTION 54 0.0003
810 BLOOD URINE PRESENT 6 0.0003
811 SENSORY DISTURBANCE 5 0.0003
812 ERYTHEMA 64 0.0003
813 BLOOD POTASSIUM INCREASED 5 0.0003
814 SOMNOLENCE 62 0.0003
815 SKIN FISSURES 6 0.0003
816 DEAFNESS 8 0.0003
817 LABORATORY TEST ABNORMAL 9 0.0003
818 JOINT STIFFNESS 8 0.0003
819 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
820 DISORIENTATION 12 0.0003
821 PANCREATITIS 16 0.0003
822 BLOOD PRESSURE ABNORMAL 6 0.0003
823 EXPIRED PRODUCT ADMINISTERED 10 0.0003
824 SKIN DISORDER 10 0.0003
825 DEVICE LEAKAGE 13 0.0003
826 SWELLING 28 0.0003
827 ANXIETY 85 0.0003
828 PRODUCT USE ISSUE 56 0.0003
829 THERAPEUTIC RESPONSE DECREASED 18 0.0003
830 FEEDING DISORDER 6 0.0003
831 RASH ERYTHEMATOUS 14 0.0003
832 DEVICE DEFECTIVE 5 0.0003
833 NECK PAIN 16 0.0003
834 EOSINOPHILIA 5 0.0003
835 LIVER INJURY 7 0.0003
836 COVID-19 50 0.0003
837 CYSTITIS 9 0.0003
838 PLASMA CELL MYELOMA 11 0.0003
839 HIP FRACTURE 9 0.0003
840 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
841 CONSTIPATION 61 0.0003
842 PARAESTHESIA 44 0.0003
843 FEELING HOT 17 0.0003
844 OSTEONECROSIS 9 0.0003
845 RASH 119 0.0003
846 VISUAL ACUITY REDUCED 9 0.0003
847 SKIN ULCER 7 0.0003
848 BLINDNESS 11 0.0003
849 STEVENS-JOHNSON SYNDROME 6 0.0003
850 TRANSAMINASES INCREASED 6 0.0003
851 DIPLOPIA 7 0.0003
852 RENAL INJURY 8 0.0003
853 AGRANULOCYTOSIS 5 0.0003
854 PAIN IN EXTREMITY 79 0.0003
855 GLOSSODYNIA 6 0.0003
856 HEPATIC CIRRHOSIS 5 0.0003
857 LUNG DISORDER 13 0.0003
858 OROPHARYNGEAL PAIN 24 0.0003
859 RENAL DISORDER 12 0.0003
860 RASH MACULAR 9 0.0003
861 BRONCHITIS 19 0.0003
862 CARDIAC DISORDER 24 0.0003
863 EMOTIONAL DISTRESS 31 0.0003
864 SKIN LESION 7 0.0003
865 HAEMATOCHEZIA 14 0.0003
866 PERIPHERAL SWELLING 39 0.0003
867 HEAD INJURY 8 0.0003
868 DISEASE RECURRENCE 12 0.0003
869 BLOOD PRESSURE FLUCTUATION 6 0.0002
870 BLISTER 14 0.0002
871 DIZZINESS 124 0.0002
872 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
873 MENTAL IMPAIRMENT 6 0.0002
874 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
875 PRURITUS 93 0.0002
876 DECREASED APPETITE 56 0.0002
877 OVERDOSE 52 0.0002
878 INTESTINAL OBSTRUCTION 9 0.0002
879 MOBILITY DECREASED 17 0.0002
880 COGNITIVE DISORDER 11 0.0002
881 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
882 LIVER FUNCTION TEST INCREASED 5 0.0002
883 PRURITUS GENERALISED 5 0.0002
884 EMOTIONAL DISORDER 7 0.0002
885 LYMPHADENOPATHY 8 0.0002
886 HALLUCINATION 17 0.0002
887 SINUSITIS 23 0.0002
888 DYSPEPSIA 22 0.0002
889 CHROMATURIA 5 0.0002
890 HYPOTHYROIDISM 7 0.0002
891 CATARACT 13 0.0002
892 FATIGUE 169 0.0002
893 DIVERTICULITIS 6 0.0002
894 WOUND 6 0.0002
895 VIRAL INFECTION 7 0.0002
896 SYNCOPE 21 0.0002
897 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
898 HYPOGLYCAEMIA 10 0.0002
899 PALPITATIONS 24 0.0002
900 DIARRHOEA 132 0.0002
901 PSYCHOTIC DISORDER 6 0.0002
902 LIVER DISORDER 9 0.0002
903 RHINORRHOEA 13 0.0002
904 BURNING SENSATION 14 0.0002
905 INCORRECT DOSE ADMINISTERED 45 0.0002
906 NEPHROLITHIASIS 9 0.0002
907 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
908 FEMUR FRACTURE 6 0.0002
909 VISUAL IMPAIRMENT 24 0.0002
910 ALOPECIA 38 0.0002
911 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 9 0.0002
912 WEIGHT DECREASED 53 0.0002
913 VISION BLURRED 26 0.0002
914 NIGHT SWEATS 6 0.0002
915 FEAR 5 0.0002
916 UNEVALUABLE EVENT 14 0.0002
917 CHOLELITHIASIS 6 0.0002
918 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
919 AGGRESSION 9 0.0002
920 DEMENTIA 5 0.0002
921 UNDERDOSE 13 0.0002
922 GAIT DISTURBANCE 34 0.0002
923 TREMOR 29 0.0002
924 NEOPLASM PROGRESSION 6 0.0002
925 DYSKINESIA 7 0.0002
926 BONE PAIN 10 0.0002
927 ARTHRALGIA 70 0.0002
928 FALL 56 0.0002
929 GASTROINTESTINAL DISORDER 15 0.0002
930 EYE SWELLING 6 0.0002
931 LEUKOPENIA 8 0.0002
932 MUSCLE SPASMS 29 0.0002
933 AMNESIA 10 0.0002
934 NASAL CONGESTION 9 0.0002
935 DRY SKIN 20 0.0001
936 GAIT INABILITY 5 0.0001
937 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
938 DISTURBANCE IN ATTENTION 8 0.0001
939 EXTRA DOSE ADMINISTERED 6 0.0001
940 INSOMNIA 39 0.0001
941 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
942 COMPLETED SUICIDE 12 0.0001
943 RHABDOMYOLYSIS 6 0.0001
944 BLOOD GLUCOSE INCREASED 27 0.0001
945 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
946 DEPRESSION 32 0.0001
947 ARTHRITIS 11 0.0001
948 HYPOACUSIS 6 0.0001
949 MALAISE 61 0.0001
950 INJECTION SITE HAEMORRHAGE 11 0.0001
951 FLUID RETENTION 7 0.0001
952 MIGRAINE 13 0.0001
953 ABDOMINAL PAIN UPPER 28 0.0001
954 ILLNESS 14 0.0001
955 INFLAMMATION 7 0.0001
956 HEPATIC ENZYME INCREASED 9 0.0001
957 HOSPITALISATION 20 0.0001
958 EXPOSURE DURING PREGNANCY 8 0.0001
959 ABNORMAL BEHAVIOUR 5 0.0001
960 EYE PAIN 7 0.0001
961 LUNG NEOPLASM MALIGNANT 5 0.0001
962 SURGERY 7 0.0001
963 MEMORY IMPAIRMENT 16 0.0001
964 WEIGHT INCREASED 26 0.0001
965 DRUG INTOLERANCE 11 0.0001
966 RASH PRURITIC 6 0.0001
967 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
968 MYALGIA 18 0.0001
969 OCULAR HYPERAEMIA 5 0.0001
970 DIABETES MELLITUS 8 0.0001
971 HERPES ZOSTER 6 0.0001
972 BALANCE DISORDER 9 0.0001
973 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
974 INTERSTITIAL LUNG DISEASE 5 0.0001
975 INTENTIONAL PRODUCT MISUSE 9 0.0001
976 IRRITABILITY 6 0.0001
977 PRODUCT DOSE OMISSION ISSUE 29 0.0001
978 HOT FLUSH 7 0.0001
979 NASOPHARYNGITIS 17 0.0001
980 ASTHMA 10 0.0001
981 THERAPY INTERRUPTED 6 0.0001
982 SKIN EXFOLIATION 7 0.0001
983 FEELING ABNORMAL 19 0.0001
984 ABDOMINAL DISCOMFORT 13 0.0001
985 PRODUCT DOSE OMISSION 5 0.0001
986 JOINT SWELLING 9 0.0001
987 INFLUENZA 8 0.0001
988 SLEEP DISORDER 5 0.0001
989 MUSCULOSKELETAL STIFFNESS 6 0.0001
990 ADVERSE DRUG REACTION 6 0.0001
991 INJECTION SITE ERYTHEMA 8 0.0001
992 DRY MOUTH 5 0.0001
993 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
994 INFLUENZA LIKE ILLNESS 5 0.0001
995 BREAST CANCER 5 0.0001
996 TOXICITY TO VARIOUS AGENTS 8 0.0000
997 INJECTION SITE PAIN 13 0.0000